Relenza/Zanamivir
Awarded Award Notice Posted
A later notice was posted. The latest for this opportunity is the Limited / Sole Source Justification from . See the latest notice
- Solicitation number
- SPE2DP-16-R-0005
- Agency
- Land and Maritime Defense Logistics Agency, Department of Defense
- Awarded
- to Glaxosmithkline, LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- SPE2DP-16-D-0009 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
Notice text
Awarded contract SPE2DP-16-D-0009 to GlaxoSmithKline for 6,948,000.00 on 2016-09-13.
Attachments
| File | Type | Posted |
|---|---|---|
| Signed_J A_-_Redacted.pdf | ||
| Relenza_SPE2DP-16-D-0009_-_KO_Signed.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| J&A302-1SPE2DP16D0009 | Limited / Sole Source Justification | |
| Relenza/Zanamivir | Award Notice | |
| Zanamivir for Inhalation | Award Notice |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity